Suppr超能文献

恶性黑色素瘤的联合免疫疗法。脑转移后的异常生存期。

Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.

作者信息

Spitler L E, Wong P, Sagebiel R

出版信息

Arch Dermatol. 1978 Oct;114(10):1501-4.

PMID:718187
Abstract

An 18-year-old woman was found to have solitary cerebral, choroidal, and pulmonary metastases of malignant melanoma three years after excision of a primary malignant melanoma. The cerebral metastasis was excised, and the patient's condition was treated with CNS irradiation followed by combined immunotherapy with transfer factor and Bacille bilié de Calmette-Guérin. The transfer factor donor was her father, who showed cellular immunity to melanoma extracts on in vitro testing. Histologic examination of the pulmonary nodule, which was excised after the initiation of immunotherapy, revealed a dense lymphocytic infiltrate associated with the metastatic melanoma. The patient is currently free of detectable melanoma more than three years after the cerebral metastasis. Studies in a second patient also demonstrated the appearance of inflammatory infiltrate in metastatic melanoma following transfer factor therapy.

摘要

一名18岁女性在原发性恶性黑色素瘤切除三年后,被发现患有孤立性脑、脉络膜和肺转移瘤。切除了脑转移瘤,患者接受了中枢神经系统放疗,随后用转移因子和卡介苗进行联合免疫治疗。转移因子供体是她的父亲,体外检测显示其对黑色素瘤提取物具有细胞免疫。免疫治疗开始后切除的肺结节组织学检查显示,转移性黑色素瘤伴有密集的淋巴细胞浸润。该患者在脑转移后三年多目前未检测到黑色素瘤。对第二名患者的研究也表明,转移因子治疗后转移性黑色素瘤出现炎症浸润。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验